Alamar Biosciences, Inc. ALMR
27.39 USD -2.83 (-9.36%)
At closeNov 4, 2026, 4:00 PM EST
27.39 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
25.32 Day range 29.08
18.85 52-week range 39.61
- YTD
- +24.50%
- 1 year
- +24.50%
Financial health
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -48.9×
FY 2024 5y median -24.4× FY 2025
P/S 19.7×
FY 2024 5y median 9.9× FY 2025
P/B -9.2×
FY 2024 5y median -4.6× FY 2025
P/FCF -24.4×
FY 2024 5y median -12.2× FY 2025
EV/EBITDA -59.3×
FY 2024 5y median -29.6× FY 2025
EV/Sales 19.9×
FY 2024 5y median 9.9× FY 2025
FCF Yield -4.1%
FY 2024 5y median -2.0% FY 2025
Profitability
Gross Margin 56.2%
FY 2024 5y median 28.1% FY 2025
Operating Margin -42.2%
FY 2024 5y median -21.1% FY 2025
Net Margin -40.2%
FY 2024 5y median -20.1% FY 2025
ROE 18.8%
FY 2024 5y median 9.4% FY 2025
ROIC -26.5%
FY 2024 5y median -13.2% FY 2025
ROA -21.3%
FY 2024 5y median -10.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income 0.0%
FY 2024 FY 2025
EPS (diluted) 0.0%
FY 2024 FY 2025
Free Cash Flow 0.0%
FY 2024 FY 2025
Financial Health
Current Ratio 4.0×
FY 2024 5y median 5.2× FY 2025
Quick Ratio 2.4×
FY 2024 5y median 4.0× FY 2025
Debt / Equity -0.3×
FY 2024 5y median -0.3× FY 2025
Net Debt / EBITDA -0.5×
FY 2024 5y median -0.2× FY 2025
Interest Coverage -78.1×
FY 2024 5y median -39.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31